VYGR
Price
$3.24
Change
-$0.07 (-2.11%)
Updated
Jul 25 closing price
Capitalization
179.29M
5 days until earnings call
XNCR
Price
$9.24
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
657.62M
4 days until earnings call
Interact to see
Advertisement

VYGR vs XNCR

Header iconVYGR vs XNCR Comparison
Open Charts VYGR vs XNCRBanner chart's image
Voyager Therapeutics
Price$3.24
Change-$0.07 (-2.11%)
Volume$581.88K
Capitalization179.29M
Xencor
Price$9.24
Change-$0.00 (-0.00%)
Volume$454.8K
Capitalization657.62M
VYGR vs XNCR Comparison Chart in %
Loading...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VYGR vs. XNCR commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VYGR is a StrongBuy and XNCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (VYGR: $3.24 vs. XNCR: $9.24)
Brand notoriety: VYGR and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VYGR: 81% vs. XNCR: 56%
Market capitalization -- VYGR: $179.29M vs. XNCR: $657.62M
VYGR [@Biotechnology] is valued at $179.29M. XNCR’s [@Biotechnology] market capitalization is $657.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VYGR’s FA Score shows that 2 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • VYGR’s FA Score: 2 green, 3 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VYGR’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • VYGR’s TA Score: 4 bullish, 4 bearish.
  • XNCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than VYGR.

Price Growth

VYGR (@Biotechnology) experienced а 0.00% price change this week, while XNCR (@Biotechnology) price change was +3.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

VYGR is expected to report earnings on Nov 18, 2025.

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($658M) has a higher market cap than VYGR($179M). VYGR YTD gains are higher at: -42.857 vs. XNCR (-59.791). VYGR has higher annual earnings (EBITDA): -97.25M vs. XNCR (-161.68M). XNCR has more cash in the bank: 470M vs. VYGR (236M). VYGR has less debt than XNCR: VYGR (42M) vs XNCR (67.8M). XNCR has higher revenues than VYGR: XNCR (127M) vs VYGR (67M).
VYGRXNCRVYGR / XNCR
Capitalization179M658M27%
EBITDA-97.25M-161.68M60%
Gain YTD-42.857-59.79172%
P/E Ratio6.00N/A-
Revenue67M127M53%
Total Cash236M470M50%
Total Debt42M67.8M62%
FUNDAMENTALS RATINGS
VYGR vs XNCR: Fundamental Ratings
VYGR
XNCR
OUTLOOK RATING
1..100
748
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (32) in the Biotechnology industry is somewhat better than the same rating for XNCR (78). This means that VYGR’s stock grew somewhat faster than XNCR’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as XNCR (100). This means that VYGR’s stock grew similarly to XNCR’s over the last 12 months.

VYGR's SMR Rating (95) in the Biotechnology industry is in the same range as XNCR (96). This means that VYGR’s stock grew similarly to XNCR’s over the last 12 months.

VYGR's Price Growth Rating (64) in the Biotechnology industry is in the same range as XNCR (64). This means that VYGR’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's P/E Growth Rating (4) in the Biotechnology industry is in the same range as VYGR (9). This means that XNCR’s stock grew similarly to VYGR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VYGRXNCR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 16 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWGIX26.10N/A
N/A
Impax US Sustainable Economy Instl
VSOIX45.86N/A
N/A
Victory Sycamore Small Company Opp I
JNVMX18.14N/A
N/A
JPMorgan Developed International ValueR6
MGTCX9.48N/A
N/A
Transamerica Mid Cap Growth C
NSFJX6.84N/A
N/A
Natixis Target Retirement 2045 N